Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Exchange Rate Effect: 2018-2024

Historic Exchange Rate Effect for Silence Therapeutics (SLN) over the last 7 years, with Dec 2024 value amounting to $60,000.

  • Silence Therapeutics' Exchange Rate Effect fell 139.55% to -$106,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $165,000, marking a year-over-year increase of 1684.68%. This contributed to the annual value of $60,000 for FY2024, which is 91.99% down from last year.
  • Per Silence Therapeutics' latest filing, its Exchange Rate Effect stood at $60,000 for FY2024, which was down 91.99% from $749,000 recorded in FY2023.
  • Silence Therapeutics' 5-year Exchange Rate Effect high stood at $749,000 for FY2023, and its period low was -$8.1 million during FY2022.
  • For the 3-year period, Silence Therapeutics' Exchange Rate Effect averaged around -$2.4 million, with its median value being $60,000 (2024).
  • In the last 5 years, Silence Therapeutics' Exchange Rate Effect plummeted by 5,519.96% in 2022 and then spiked by 109.23% in 2023.
  • Yearly analysis of 5 years shows Silence Therapeutics' Exchange Rate Effect stood at -$431,473 in 2020, then surged by 66.52% to -$144,467 in 2021, then slumped by 5,519.96% to -$8.1 million in 2022, then surged by 109.23% to $749,000 in 2023, then plummeted by 91.99% to $60,000 in 2024.